Parallax Volatility Advisers
CLOV icon

Parallax Volatility Advisers’s Clover Health Investments CLOV Stock Holding History

Parallax Volatility Advisers’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-19,855
Closed -$62.5K – 1635
2024
Q4 		$62.5K Buy
19,855
+6,408
+48% +$22.9K ﹤0.01% 1765
2024
Q3 		$37.9K Buy
+13,447
New +$30.8K ﹤0.01% 1854
2024
Q1 		– Sell
-11,694
Closed -$11.1K – 1896
2023
Q4 		$11.1K Sell
11,694
-29,152
-71% -$28.6K ﹤0.01% 2024
2023
Q3 		$44.1K Sell
40,846
-161,478
-80% -$192K ﹤0.01% 2024
2023
Q2 		$182K Buy
202,324
+191,042
+1,693% +$169K ﹤0.01% 1903
2023
Q1 		$9.53K Buy
11,282
+1,502
+15% +$1.64K ﹤0.01% 2405
2022
Q4 		$9.09K Buy
+9,780
New +$13.1K ﹤0.01% 2569
2022
Q3 		– Sell
-10,194
Closed -$22K – 3089
2022
Q2 		$22K Buy
+10,194
New +$27.1K ﹤0.01% 2572

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Parallax Volatility Advisers's CLOV Position: Q1 2025 in Review

Parallax Volatility Advisers sold out of Clover Health Investments (CLOV) in Q1 2025, closing a stake of 19,855 shares — an estimated $62.5K sold.

Parallax Volatility Advisers first reported a position in CLOV in Q2 2022 and held it in 8 quarters. The position peaked at $182K in Q2 2023. 202 funds tracked by Wall St. Rank hold CLOV as of Q1 2025.

  • Parallax Volatility Advisers reported no remaining Clover Health Investments position as of Q1 2025 after selling out during the quarter.
  • Parallax Volatility Advisers sold 19,855 Clover Health Investments shares in Q1 2025, an estimated $62.5K.
  • Parallax Volatility Advisers first reported a position in Clover Health Investments in Q2 2022 and held it in 8 quarters.
  • Parallax Volatility Advisers's Clover Health Investments position peaked at $182K in Q2 2023.
  • 202 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2025.

Based on Parallax Volatility Advisers's 13F filing for Q1 2025, filed 15 May 2025.